1.0Trade Brains Featureshttps://tradebrains.in/featuresPTI Newshttps://tradebrains.in/features/author/ptinews/InvaGen to continue to hold shares in Avenue Therapeutics: Ciplarich600338<blockquote class="wp-embedded-content" data-secret="QA1ozm0UsA"><a href="https://tradebrains.in/features/biz-invagen-avenue/">InvaGen to continue to hold shares in Avenue Therapeutics: Cipla</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://tradebrains.in/features/biz-invagen-avenue/embed/#?secret=QA1ozm0UsA" width="600" height="338" title="“InvaGen to continue to hold shares in Avenue Therapeutics: Cipla” — Trade Brains Features" data-secret="QA1ozm0UsA" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]> */
</script>
New Delhi, Jan 12 (PTI) Drug major Cipla on Wednesday said its subsidiary InvaGen Pharmaceuticals will continue to hold shares in US-based Avenue Therapeutics despite termination of the stock purchase and merger agreement they inked in 2018. In November 2018, Cipla had announced that InvaGen Pharmaceuticals Inc has entered into definitive agreements to acquire US-based […]